vimarsana.com
Home
Live Updates
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery : vimarsana.com
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
Study led by Weill Cornell Medicine demonstrates identification of protein altering variants for population-scale protein quantitative trait loci studies Proteograph Product Suite enables scalable...
Related Keywords
Qatar ,
Omid Farokhzad ,
Patrick Schmidt ,
Serafim Batzoglou ,
Karsten Suhre ,
Weill Cornell ,
Carrie Mendivil ,
Nasdaq ,
Nature Communications ,
Exchange Commission ,
Seer Inc ,
Weill Cornell Medicine ,
Product Suite ,
Virtual Metabolomics Core ,
Weill Cornell Medicine Qatar ,
Proteograph Assay ,
Chief Executive Officer ,
Proteograph Product Suite ,
Chief Data Officer ,
Private Securities Litigation Reform Act ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.